Just went through my mom's discharge papers from March 2nd, 2009. To give some context: she was discharged on January 8th, 2009, with a diagnosis of Hodgkin's disease, CD34+ cell collection. From February 9th to February 27th, 2009, she was in the ICU for an autologous peripheral stem cell transplant. After the BEAM chemotherapy conditioning regimen—which included Carmustine (477 mg in 500 ml IV on day 6), Etoposide (318 mg in 250 ml IV from days 5 to 2), Cytarabine (2x 318 mg in 250 ml IV), and Melfalan (223 mg IV on day 1)—they did the peripheral stem cell reinfusion on February 16th. The post-chemo period was messy, dealing with pancytopenia complicated by fever and mucositis. No significant pathogens showed up in the micro tests, and the piperacillin/tazobactam treatment helped clear things up and bring the fever down. Because of neutropenia, she got daily Filgrastim (600 mcg) for 8 days. She also needed several red blood cell transfusions (520 ml) and about 22 doses of platelets due to anemia and thrombocytopenia. She was discharged in good condition 17 days after the transplant with the diagnosis of Hodgkin's disease C81
Autologous bone marrow transplant (PBSCT) at 94.8%
What I'm trying to figure out is: does a change in the diagnosis code mean her condition is better or worse? She’s heading back to the hospital in early April for more testing to get a factual look at where things stand. Thanks in advance, and sorry for the long-winded post!
Autologous bone marrow transplant (PBSCT) at 94.8%
What I'm trying to figure out is: does a change in the diagnosis code mean her condition is better or worse? She’s heading back to the hospital in early April for more testing to get a factual look at where things stand. Thanks in advance, and sorry for the long-winded post!